Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results

杜皮鲁玛 慢性鼻-鼻窦炎 鼻息肉 医学 窦(植物学) 皮肤病科 鼻窦炎 内科学 胃肠病学 免疫学 特应性皮炎 生物 植物
作者
Claus Bachert,Tanya M. Laidlaw,Seong Ho Cho,Joaquim Mullol,Brian N. Swanson,Souâd Naimi,Marion Classe,Sivan Harel,Alexandre Jagerschmidt,Elizabeth Laws,Marcella Ruddy,Amy Praestgaard,Nikhil Amin,Leda Mannent
出处
期刊:Annals of Otology, Rhinology, and Laryngology [SAGE]
卷期号:132 (12): 1649-1661 被引量:1
标识
DOI:10.1177/00034894231176334
摘要

Chronic rhinosinusitis with nasal polyps (CRSwNP), asthma, and non-steroidal anti-inflammatory drug-exacerbated respiratory disease (NSAID-ERD) are frequent coexisting conditions and share type 2 inflammatory pathophysiology, with interleukin (IL)-4 and IL-13 as key cytokines. Dupilumab is a monoclonal antibody that blocks the shared receptor for IL-4 and IL-13. The objective of this analysis was to evaluate dupilumab's effect on type 2 inflammation biomarkers in patients with CRSwNP with/without coexisting asthma or NSAID-ERD from the SINUS-52 (NCT02898454) study.Patients received treatment with dupilumab or placebo for 52 weeks. Blood and urinary biomarkers were evaluated through 52 weeks, and nasal secretions and mucosa brushings through 24 weeks.Of 447 patients, 60% had coexisting asthma and 27% had coexisting NSAID-ERD. At baseline, blood eotaxin-3, eosinophils, and periostin, nasal secretion eotaxin-3, and urinary leukotriene E4 were significantly higher in patients with coexisting NSAID-ERD than without. Dupilumab reduced eotaxin-3, thymus and activation-regulated chemokine, periostin, and total immunoglobulin E in blood, eotaxin-3, periostin, IL-5, and eosinophil cationic protein in nasal secretions, and leukotriene E4 in urine. Reductions were generally similar or greater in the subgroups with asthma and NSAID-ERD than without. Dupilumab also reduced MUC5AC and mast cell counts in nasal mucosa brushings.Dupilumab reduced local and systemic type 2 inflammatory biomarkers in patients with CRSwNP, including mast cells in nasal mucosa and cysteinyl leukotrienes in urine. These findings provide insight into the processes driving CRSwNP and the mechanisms of dupilumab's therapeutic effects.SINUS-52 https://www.clinicaltrials.gov/ct2/show/NCT02898454.NCT02898454.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
orixero应助shh12采纳,获得10
刚刚
暖若安阳完成签到,获得积分10
刚刚
刚刚
刚刚
刚刚
刚刚
1秒前
大麦迪完成签到,获得积分10
1秒前
个性的孤风完成签到,获得积分10
1秒前
春与修罗应助张东泽采纳,获得10
1秒前
畅畅完成签到,获得积分10
1秒前
脑洞疼应助Yancy采纳,获得10
2秒前
gyhk发布了新的文献求助10
2秒前
慕青应助du采纳,获得10
2秒前
3秒前
pzh完成签到 ,获得积分20
4秒前
吴雨涛发布了新的文献求助10
4秒前
超帅夫发布了新的文献求助10
5秒前
布丁果冻完成签到,获得积分10
5秒前
在水一方应助容止采纳,获得10
5秒前
长颈鹿发布了新的文献求助10
5秒前
所所应助YOLO采纳,获得10
5秒前
科研通AI5应助森sen采纳,获得10
5秒前
5秒前
here发布了新的文献求助30
6秒前
magneto发布了新的文献求助10
6秒前
马马马完成签到,获得积分10
6秒前
6秒前
善学以致用应助Zhang_BY采纳,获得10
7秒前
缪伟发布了新的文献求助10
7秒前
wy18567337203完成签到,获得积分10
8秒前
HJJHJH发布了新的文献求助30
8秒前
8秒前
搞怪的怀蕊完成签到,获得积分10
9秒前
高源发布了新的文献求助10
9秒前
马马马发布了新的文献求助10
9秒前
pp1230发布了新的文献求助10
9秒前
无花果应助m123采纳,获得10
10秒前
lemon完成签到,获得积分10
10秒前
11秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Mechanistic Modeling of Gas-Liquid Two-Phase Flow in Pipes 2500
Kelsen’s Legacy: Legal Normativity, International Law and Democracy 1000
Handbook on Inequality and Social Capital 800
Conference Record, IAS Annual Meeting 1977 610
Interest Rate Modeling. Volume 3: Products and Risk Management 600
Interest Rate Modeling. Volume 2: Term Structure Models 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3546676
求助须知:如何正确求助?哪些是违规求助? 3123726
关于积分的说明 9356475
捐赠科研通 2822353
什么是DOI,文献DOI怎么找? 1551369
邀请新用户注册赠送积分活动 723332
科研通“疑难数据库(出版商)”最低求助积分说明 713721